Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

499
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
499
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

433
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
433
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

390
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
390

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sparse-Observation Multi-Horizon Glaucoma Progression Forecasting with Biologically Constrained Temporal Consistency: A Glaucoma Case Study.

Research square·2026
Same author

Perimetric Outcomes of Melbourne Rapid Field Perimetry in Patients With Glaucoma: A Systematic Review and Meta-Analysis.

Journal of glaucoma·2026
Same author

Locally-affiliated authorship in global eye health research conducted in Sub-Saharan Africa between 2003 and 2022.

Eye (London, England)·2026
Same author

FORGE: Functionally-guided OCT Representation for Glaucoma Endophenotyping.

medRxiv : the preprint server for health sciences·2026
Same author

Outcomes of Minimally Invasive Glaucoma Surgery, Trabeculectomy, and Tube Shunt Surgery in Secondary Glaucoma: IRIS® Registry Analysis.

American journal of ophthalmology·2026
Same author

Comparison of Glaucoma Surgery Incidence and Outcomes in Pigmentary and Primary Open-Angle Glaucoma: IRIS® Registry Analysis.

Ophthalmology·2026

Related Experiment Video

Updated: Jun 1, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.3K

Equitable artificial intelligence for glaucoma screening with fair identity normalization.

Min Shi1, Yan Luo1, Yu Tian1

  • 1Harvard Ophthalmology AI Lab, Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.

NPJ Digital Medicine
|January 20, 2025
PubMed
Summary
This summary is machine-generated.

A new fair identify normalization (FIN) module improves deep learning models for glaucoma detection, ensuring equitable performance across racial and ethnic groups. This advancement helps reduce health disparities in diagnosing irreversible blindness.

More Related Videos

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

292
Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
05:49

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

706

Related Experiment Videos

Last Updated: Jun 1, 2025

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

6.3K
Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss
07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

292
Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
05:49

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

706

Area of Science:

  • Ophthalmology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Glaucoma is a primary cause of irreversible blindness worldwide.
  • Racial and ethnic minorities are disproportionately affected by glaucoma.
  • Current deep learning models may exhibit performance disparities across diverse populations.

Purpose of the Study:

  • To develop a novel module for enhancing fairness in deep learning models for glaucoma detection.
  • To improve the equity of model performance across different racial and ethnic groups.
  • To address the challenge of unequal performance in AI-driven diagnostic tools.

Main Methods:

  • Utilized optical coherence tomography (OCT) measurements for glaucoma and non-glaucoma classification.
  • Developed and implemented a fair identify normalization (FIN) module.
  • Employed equity-scaled area under the receiver operating characteristic curve (ES-AUC) to measure performance equity.

Main Results:

  • The FIN module improved overall AUC from 0.82 to 0.85 for racial groups, with AUC for Black individuals increasing from 0.77 to 0.82.
  • ES-AUC increased from 0.77 to 0.81 for racial groups after applying FIN.
  • For ethnic groups, overall AUC rose from 0.82 to 0.84, and ES-AUC from 0.77 to 0.80, with Hispanic individuals' AUC improving from 0.75 to 0.79.

Conclusions:

  • The fair identify normalization (FIN) module significantly enhances the equity of deep learning models for glaucoma detection.
  • FIN improves diagnostic performance across diverse racial and ethnic groups, mitigating existing disparities.
  • This approach holds promise for more equitable AI-based healthcare solutions in ophthalmology.